ArticleHepatology international2022

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study.

Jitao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.